"If you take [Medicare Part
B's "buy-and-bill" practice] away, then doctors will stop doing it in
their physician-office setting, and more and more volume will shift to
[hospitals], which will jack up the prices even more."
— Jay Godla, a partner with PWC's
consulting practice Strategy&, talked with AIS's RADAR on Drug Benefits
about potential problems that could be caused by a new federal proposal to
change Medicare Part B's reimbursement system.
No comments:
Post a Comment